PHVS
Pharvaris N.V.
Pharvaris N.V. (PHVS) has 24 SEC Form 4 filings (66 transaction rows) in the rolling window, disclosed by 11 distinct insiders. Most recent filing: Jul 15, 2026.
The most active filer is Chief Medical Officer Lu Peng with 6 filings. Insiders have net sold $11.0M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Berndt Modig
- Employees:129
- HQ:Leiden, ZH, NL
- IPO:2021-02-04
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$11.0M
reported sales (SEC code S)
Unique Insiders
11
in the rolling window
Market Cap
$2.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 2,292 | $80K | Jul 15 | SEC ↗ | |
| Director | Sale | 9,288 | $326K | Jul 1 | SEC ↗ | |
| Director | Sale | 30,712 | $1.1M | Jul 1 | SEC ↗ | |
| Chief Early Development | Sale | 17,597 | $617K | Jul 1 | SEC ↗ | |
| Chief Early Development | Sale | 58,575 | $2.1M | Jul 1 | SEC ↗ | |
| Chief Early Development | Sale | 4,600 | $162K | Jun 29 | SEC ↗ | |
| Chief Medical Officer | Sale | 15,000 | $519K | Jun 29 | SEC ↗ | |
| Chief Medical Officer | Sale | 14,700 | $500K | Jun 29 | SEC ↗ | |
| Chief Medical Officer | Sale | 300 | $10K | Jun 23 | SEC ↗ | |
| Chief Executive Officer | Sale | 2,291 | $71K | Jun 17 | SEC ↗ | |
| Principal Accounting Officer | Sale | 2,670 | $82K | Jun 8 | SEC ↗ | |
Monges VivianeFirst filing | Director | Sale | 9,667 | $293K | May 26 | SEC ↗ |
Nijdam AnnaFirst filing | Principal Accounting Officer | Sale | 1,829 | $56K | May 26 | SEC ↗ |
Nijdam AnnaFirst filing | Principal Accounting Officer | Sale | 5,501 | $169K | May 26 | SEC ↗ |
Nassif David W.First filing | CFO / CLO | Sale | 10,000 | $303K | May 26 | SEC ↗ |
Bjork ElisabethFirst filing | Director | Sale | 10,000 | $293K | May 22 | SEC ↗ |
Modig BerndtFirst filing | Chief Executive Officer | Sale | 2,292 | $67K | May 20 | SEC ↗ |
Glassman RobertFirst filing | Director | Sale | 10,000 | $298K | May 19 | SEC ↗ |
Abele Stefan AndreasFirst filing | Chief Technical Ops Officer | Sale | 8,748 | $261K | May 19 | SEC ↗ |
Souverijns WimFirst filing | Chief Commercial Officer | Sale | 10,000 | $299K | May 19 | SEC ↗ |
| Chief Medical Officer | Sale | 14,166 | $427K | May 5 | SEC ↗ | |
Schikan Johannes Gerardus Christiaan PetrusFirst filing | Insider | Sale | 3,830 | $115K | May 1 | SEC ↗ |
Schikan Johannes Gerardus Christiaan PetrusFirst filing | Insider | Sale | 29,070 | $881K | May 1 | SEC ↗ |
Lesage AnneFirst filing | Chief Early Development | Sale | 7,400 | $223K | May 1 | SEC ↗ |
Lesage AnneFirst filing | Chief Early Development | Sale | 40,900 | $1.2M | May 1 | SEC ↗ |
Lu PengFirst filing | Chief Medical Officer | Sale | 3,733 | $112K | May 1 | SEC ↗ |
Lu PengFirst filing | Chief Medical Officer | Sale | 15,000 | $454K | May 1 | SEC ↗ |
Related companies
Pharvaris N.V. is in the Healthcare sector.